Fatal Complications in Candida parapsilosis Endocarditis—A Case Report
Open Access
- 18 November 2025
- journal article
- case report
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (11) , 817
Abstract
Fungal endocarditis, despite being a rare diagnosis, has a higher morbidity and mortality rate compared to bacterial endocarditis. Candida species are the most common isolated pathogens involved in fungal endocarditis. Diagnosis is suspected in patients with underlying conditions such as cancer, myelodysplastic syndrome, diabetes, or intravascular catheters, where the modified Duke criteria apply. Management of the patient requires a multidisciplinary team (cardiologist, infectious diseases consultant, cardiac surgeon) along with antifungal treatment. We present the case of a 60-year-old male with biological prosthetic aortic valve replacement in the previous year for bicuspid aortic stenosis, admitted for a 5-day history of fever, nausea and minor urinary symptoms. The blood cultures were positive for Candida parapsilosis. Transthoracic cardiac ultrasound revealed a hypoechogenic mass attached to the aortic valve at the prosthetic fixation site. Although diagnosis was rapidly confirmed and treatment was administered shortly after first suspected, the patient developed, at first, cavernous sinus thrombosis and, later, fatal ST elevation myocardial infarction. The patient died despite efficient antifungal therapy, initially with Anidulafungin in monotherapy and later in combination with Fluconazole. The reported case emphasizes the importance of managing fungal endocarditis, the need for urgent diagnostic attention and multidisciplinary team approach by infectious diseases specialist, cardiologist, neurologist and heart surgeon.Keywords
This publication has 21 references indexed in Scilit:
- Antifungal Therapy in Candida Infective Endocarditis: A Comparison of Echinocandins and Other Treatment Regimens in a Nationwide Cohort StudyClinical Infectious Diseases, 2025
- 2023 ESC Guidelines for the management of endocarditisEuropean Heart Journal, 2023
- Risk factors predicting Candida infective endocarditis in patients with candidemiaMedical Mycology, 2020
- Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis—The ESCAPE StudyClinical Infectious Diseases, 2017
- Anidulafungin for the treatment of invasive candidiasisClinical Microbiology and Infection, 2011
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st CenturyArchives of internal medicine (1960), 2009
- Candida infective endocarditisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Anidulafungin versus Fluconazole for Invasive CandidiasisNew England Journal of Medicine, 2007
- Post-operative aspergillosisClinical Microbiology and Infection, 2006
- Candidabiofilm: a well-designed protected environmentMedical Mycology, 2005